Results 1 to 10 of about 6,798 (212)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells.

open access: yesPLoS ONE, 2021
Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approved.
Yingyun Cai   +5 more
doaj   +2 more sources

Separation of bivalent anti-T cell immunotoxin from Pichia pastoris glycoproteins by borate anion exchange

open access: yesBioTechniques, 2003
A major problem encountered in the large-scale purification of the bivalent anti-T cell immunotoxin, A-dmDT390-bisFv(G4S), from Pichia pastoris supernatants was the presence of host glycoproteins exhibiting similar charge, size, and hydrophobicity ...
Jung Hee Woo, David M. Neville
doaj   +2 more sources

Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells [PDF]

open access: yesImmunoAnalysis, 2021
Background: Tumor growth and progression depend largely on the activity of cell membrane receptors like epidermal growth factor receptor (EGFR). This receptor plays a significant role in the growth and survival of many solid tumors.
Khalil Hajiasgharzadeh   +2 more
doaj   +1 more source

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): A variety of signaling molecules have been identified that play a role in angiogenesis, of prime importance, vascular endothelial growth factor (VEGF) and its resceptor (VEGFR), which is highly expressed in most human solid tumors ...
Mohammad Hosseininejad-Chafi   +9 more
doaj   +1 more source

Engineering and production of recombinant bovine pancreatic ribonuclease enzyme (RNase A) as a potential therapeutic [PDF]

open access: yesمجله بیوتکنولوژی کشاورزی, 2021
Objective  Immunotoxins are one of the most promising ways in therapeutic fields, specially cancer therapy which have a unique toxin-antibody structure, and kill the cancer cell by passing through the cell membrane and entering the target cell.
Masoume Vakili-Azghandi   +3 more
doaj   +1 more source

Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861

open access: yesFrontiers in Pharmacology, 2023
Immunotoxins consist of an antibody or antibody fragment that binds to a specific cell surface structure and a cytotoxic domain that kills the cell after cytosolic uptake. Pseudomonas Exotoxin A (PE) based immunotoxins directed against a variety of tumor
Anie P. Masilamani   +25 more
doaj   +1 more source

Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P. [PDF]

open access: yesPLoS ONE, 2013
Activated protein kinase C (PKC) contributes to tumor survival and proliferation, provoking the development of inhibitory agents as potential cancer therapeutics.
Abid R Mattoo   +2 more
doaj   +1 more source

Targeted delivery of immunotoxin by antibody to ganglioside GD3: a novel drug delivery route for tumor cells. [PDF]

open access: yesPLoS ONE, 2013
Gangliosides are sialic acid-containing glycolipids expressed on plasma membranes from nearly all vertebrate cells. The expression of ganglioside GD3, which plays essential roles in normal brain development, decreases in adults but is up regulated in ...
Vanina Torres Demichelis   +4 more
doaj   +1 more source

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin

open access: yesOncoImmunology, 2019
Granulysin is a protein present in the granules of human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, with cytolytic activity against microbes and tumors.
Raquel Ibáñez-Pérez   +11 more
doaj   +1 more source

Antiviral Activity of Ribosome-Inactivating Proteins

open access: yesToxins, 2021
Ribosome-inactivating proteins (RIPs) are rRNA N-glycosylases from plants (EC 3.2.2.22) that inactivate ribosomes thus inhibiting protein synthesis. The antiviral properties of RIPs have been investigated for more than four decades.
Lucía Citores   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy